Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin - Wikidata - awgldk - TriplyDB

Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin

Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin

http://www.wikidata.org/entity/Q35535689

about

Candida Biofilms: Development, Architecture, and Resistance Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.Microbial interactions in building of communities.Discovery and biological characterization of the auromomycin chromophore as an inhibitor of biofilm formation in Vibrio cholerae.Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.Chitosan sponges for local synergistic infection therapy: a pilot study.Biofilm formation mechanisms and targets for developing antibiofilm agents.Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm.Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms.Effect of tyrosol on adhesion of Candida albicans and Candida glabrata to acrylic surfaces.Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.Farnesol inhibits development of caries by augmenting oxygen sensitivity and suppressing virulence-associated gene expression inStreptococcus mutans.Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.

P2860

Q26782611-2A368985-246B-4422-82B0-EE0817DCD764 Q26799027-1BDC935F-2F8B-4AD2-A9EA-1BDE9CA3C846 Q34271793-7EC3EB0E-E43A-4011-82C5-11C37FE77B3A Q34518087-0DA235B9-EAD8-4176-8FDD-826B2380B6C9 Q35012316-5216180C-A6E1-44FD-8A11-3C8EE1DAD9A3 Q35042582-B764C462-AD0F-47D1-B373-DFFCB8FC795F Q35152853-FEF82456-7873-4637-9A92-A328A222A118 Q37170954-565529DD-AF27-45B7-9D20-0C2C8B74FCC5 Q38421808-FB1D4AE1-4F62-4B57-B04F-F23DC275D3E9 Q39501793-D2E832EE-B363-4833-BD16-DA9342CDB5BB Q40169526-C57B6F30-B7C2-4573-BA30-C536FF66BCDF Q40750692-2912D521-E0CC-48FD-815B-F763F0B9873C Q40836726-B6F6BD68-D687-47C4-997D-C70A4495EE23 Q41995789-16666E0C-5E79-4E53-BE2B-9F90B7321726 Q46308749-B3F673CC-3C2A-4BF3-8E75-C453D85FC670

P2860

Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin

http://www.wikidata.org/entity/Q35535689

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@ast

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@en

type

label

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@ast

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@en

prefLabel

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@ast

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@en

P1433

Q35535689-E84A32B2-6734-419C-8840-392B1FB54E08

P1476

Q35535689-29E260E0-01F3-4A4D-A3D8-F07ECA142E5C

P2093

Q35535689-213B753D-94D7-45CD-94A9-C33AC2710269

Q35535689-450B966A-5431-4F45-95F7-503179783355

Q35535689-5BC614D5-DDBC-4814-A2E2-C102AB115EFE

Q35535689-BB8C7560-3195-42B7-9F9B-7BDBD2BBAD48

Q35535689-FB016797-9822-43A9-A3F2-F2DAED7A08AB

P2860

Q35535689-04DD7C02-DD15-485F-95B8-724E5A20846A

Q35535689-09CAB09B-3ACD-4064-B3F1-E83C6E44A16F

Q35535689-14DF4275-C97B-428A-B2DB-0F62C32DE57B

Q35535689-20A9B039-7C29-4016-806F-88AF70915BEB

Q35535689-284BAF5B-AC3F-4E8C-9533-51B756751AC3

Q35535689-34FE5202-B345-410D-A7AB-D88C5EFCE7C3

Q35535689-39C92FEA-2F1B-4051-83BC-B4F7B2BA108C

Q35535689-3F4FABC7-431A-4B55-8CED-842CBF9CFF89

Q35535689-562E96A8-FF36-415D-9E1B-A2A36A7F05AA

Q35535689-5D30EEBA-D2E3-4E27-AA3A-73C2D57D3D3D

P2888

Q35535689-AB785A74-D291-4956-8C95-F3B958C96A2A

P304

Q35535689-97BDA37F-07D5-4445-BA29-F39A5E400E8C

P31

Q35535689-C7F2CA69-EACB-454C-B995-2BBA972458F4

P356

Q35535689-6E710194-F9C1-46F4-9230-A09CE4AAB9B7

P407

Q35535689-8F407D68-64D6-48A9-A9BD-6D3FD6694A1D

P433

Q35535689-6253B71B-0494-4585-B2D3-BA7784329611

P478

Q35535689-814FF4FF-2534-4031-BD24-5AB7839FDE38

P577

Q35535689-16CF9185-3279-42FF-8C16-2F7254210EB3

P6179

Q35535689-39AC1C4F-7BDA-46F8-9817-7671D794D7D1

P698

Q35535689-C213EBA2-8225-4968-B1F7-BB3AAAD8E79A

P921

Q35535689-53B9E329-86C5-457F-A2E7-2C34283861B0

P932

Q35535689-45EC00B5-0B48-4150-87E2-CD4D40FC7738

P356

PDR.0B013E318232A984

P1433

Pediatric Research

P1476

Farnesol decreases biofilms of ...... with nafcillin and vancomycin

@en

P2093

James Versalovic

http://www.w3.org/2001/XMLSchema#string

Jim Barrish

http://www.w3.org/2001/XMLSchema#string

John M Hicks

http://www.w3.org/2001/XMLSchema#string

Mohan Pammi

http://www.w3.org/2001/XMLSchema#string

Rong Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry

Analysis of a marine phototrophic biofilm by confocal laser scanning microscopy using the new image quantification software PHLIP.

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Intravascular catheter-related infections: advances in diagnosis, prevention, and management.

Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolat

Current concepts in biofilm formation of Staphylococcus epidermidis.

Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon

Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?

Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility

Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.

P2888

pdr.0b013e318232a984

P304

578-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1203/PDR.0B013E318232A984

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046403074

http://www.w3.org/2001/XMLSchema#string

P698

21857375

http://www.w3.org/2001/XMLSchema#string

P921

P932

3210893

http://www.w3.org/2001/XMLSchema#string